Carboplatin+ Etoposide + Atezolizumab followed by Atezolizumab and Lurbinectedin: clinical trials recruiting now
Fewer than 3 recruiting trials found.
1
Recruiting trials
8
Conditions studied
5
US states with sites
14
Countries
Phase breakdown
Phase 3 1
Conditions being studied
| Condition | Trials |
|---|---|
| Lung Cancer | 1 |
| Lung Cancer Metastatic | 1 |
| Lung Cancer Stage IV | 1 |
| SCLC,Extensive Stage | 1 |
| Sclc | 1 |
| Small Cell Carcinoma | 1 |
| Small Cell Lung Cancer Extensive Stage | 1 |
| Small-cell Lung Cancer | 1 |
Recruiting trials involving Carboplatin+ Etoposide + Atezolizumab followed by Atezolizumab and Lurbinectedin
Common questions
How many recruiting trials involve Carboplatin+ Etoposide + Atezolizumab followed by Atezolizumab and Lurbinectedin?
1 recruiting trial across 8 conditions.
Is this list of trials complete?
No. For the full record, search ClinicalTrials.gov.